Trump’s Call for Transparency

Former President donald trump has⁣ publicly urged pharmaceutical companies to release data regarding the success rates of their⁣ COVID-19 ⁢”drugs,” aiming to‌ resolve ​what he ⁣describes as a “mess” surrounding the products. This demand, made via a truth Social post, ⁣highlights ongoing debates about the​ effectiveness and transparency of COVID-19 treatments.

“They show me GREAT ‌numbers‍ and results, but ⁤they don’t seem to ⁣be showing them to many others.⁤ I ‍want them⁤ to show ‌them NOW, to CDC and ⁢the public, and‍ clear up this ‍MESS, one​ way or the other!!!”

Donald Trump, Truth Social Post

Trump⁣ claims to have seen “extraordinary” information from ‍Pfizer⁢ and other companies that has not been made public.⁢ He questions why this data remains concealed, given the existing‌ division over the success of COVID-19 treatments.he ⁤did not specify wich data or “drugs” he was referring to, ‍leaving ambiguity as to ⁢whether he meant vaccines or antiviral⁣ medications like Paxlovid.

Available Data and Company Responses

While Trump suggests a lack of transparency, some ⁣data ⁢is already publicly available. Pfizer, specifically mentioned by trump, has ‌not yet​ responded ⁣to requests⁣ for comment.However, ⁤in a recent press release announcing distribution for new vaccinations, Pfizer included a link to a‌ presentation ⁤ from⁢ May detailing ​vaccine efficacy.

Similarly, Moderna’s presentation‌ from May is accessible through the Food and ⁢Drug Administration’s website. These presentations offer insights into the companies’ findings regarding vaccine performance.

Key data‍ Points ⁣from Available presentations (Example)

While ⁢specific data points ⁤vary between presentations and ‌updates, here’s an ⁣example of the type of ‍information ‌typically ‍included: